Wednesday, November 23, 2005 8:39:56 PM
http://www.dnaprint.com/welcome/press/press_recent/2005/1121/DNAG-FinalReport110405.pdf In the latest pr, there are several potential deals which could be announced at any time. Page 9 mentions several products that can be licensed when funds are avilable. Page two mentions Pfizer as an outside chance.
With the addition of two labs... Trace and Ellipse, coupled with the capabilities of Kenna, there is a good possibilty there could be a contract with?...anyone. Advancement of technologies in the ancestry lines; better financing; something totaly new is very possible too, as the sudden acquisitions bear out. ?
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM